MYCIO Wealth Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-20
Closed -$6K 267
2016
Q3
$6K Buy
20
+15
+300% +$4.44K ﹤0.01% 626
2016
Q2
$1K Buy
+5
New +$1.32K ﹤0.01% 991
2015
Q4
Sell
-15
Closed -$4K 731
2015
Q3
$4K Buy
+15
New +$4.95K ﹤0.01% 680
2014
Q4
Sell
-30
Closed -$10K 631
2014
Q3
$10K Sell
30
-50
-63% -$16.5K ﹤0.01% 450
2014
Q2
$25K Buy
80
+50
+167% +$15K 0.01% 358
2014
Q1
$9K Buy
+30
New +$9.52K ﹤0.01% 474
2013
Q3
Sell
-30
Closed -$6K 532
2013
Q2
$6K Buy
+30
New +$6.41K ﹤0.01% 456

Other funds holding BIIB

MYCIO Wealth Partners's BIIB Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Biogen (BIIB) in Q4 2016, closing a stake of 20 shares — an estimated $6K sold.

MYCIO Wealth Partners first reported a position in BIIB in Q2 2013 and held it in 7 quarters. The position peaked at $25K in Q2 2014. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • MYCIO Wealth Partners reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • MYCIO Wealth Partners sold 20 Biogen shares in Q4 2016, an estimated $6K.
  • MYCIO Wealth Partners first reported a position in Biogen in Q2 2013 and held it in 7 quarters.
  • MYCIO Wealth Partners's Biogen position peaked at $25K in Q2 2014.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.